Get the Stockscreener App
30.34
1.11%
-0.34
After Hours:
30.40
0.06
+0.20%
Hims Hers Health Inc stock is traded at $30.34, with a volume of 24.42M.
It is down -1.11% in the last 24 hours and up +39.62% over the past month.
Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermatology, primary care, and more.
See More
Previous Close:
$30.68
Open:
$31.49
24h Volume:
24.42M
Relative Volume:
1.69
Market Cap:
$6.70B
Revenue:
$1.24B
Net Income/Loss:
$101.26M
P/E Ratio:
-178.47
EPS:
-0.17
Net Cash Flow:
$149.62M
1W Performance:
+39.24%
1M Performance:
+39.62%
6M Performance:
+79.74%
1Y Performance:
+266.87%
1-Day Range:
$30.03
$35.02
1-Week Range:
$21.36
$35.02
52-Week Range:
$8.09
$35.02
Hims Hers Health Inc Stock (HIMS) Company Profile
Name
Hims Hers Health Inc
Sector
Industry
Phone
415-851-0195
Address
2269 CHESTNUT ST, SAN FRANCISCO
Compare HIMS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HIMS
Hims Hers Health Inc
|
30.34 | 6.70B | 1.24B | 101.26M | 149.62M | -0.17 |
|
PG
Procter Gamble Co
|
179.36 | 423.57B | 83.91B | 14.32B | 15.85B | 6.16 |
|
UL
Unilever Plc Adr
|
59.74 | 147.89B | 64.93B | 7.15B | 0 | 3.4285 |
|
CL
Colgate Palmolive Co
|
96.76 | 79.57B | 20.11B | 2.87B | 3.40B | 1.92 |
|
KMB
Kimberly Clark Corp
|
139.20 | 46.76B | 20.10B | 2.61B | 2.90B | 5.20 |
|
KVUE
Kenvue Inc
|
24.13 | 46.69B | 15.46B | 1.06B | 1.40B | 0.496 |
Hims Hers Health Inc Stock (HIMS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-14-24 | Downgrade | BofA Securities | Buy → Underperform |
| Aug-22-24 | Initiated | Needham | Buy |
| Aug-09-24 | Downgrade | Imperial Capital | Outperform → In-line |
| May-22-24 | Downgrade | Citigroup | Buy → Neutral |
| Apr-16-24 | Downgrade | Jefferies | Buy → Hold |
| Apr-10-24 | Initiated | Canaccord Genuity | Buy |
| Feb-28-24 | Upgrade | Imperial Capital | In-line → Outperform |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Dec-07-23 | Initiated | Imperial Capital | In-line |
| Jul-28-23 | Initiated | TD Cowen | Outperform |
| Apr-11-23 | Initiated | Robert W. Baird | Neutral |
| Feb-09-23 | Upgrade | Jefferies | Hold → Buy |
| Nov-08-22 | Upgrade | BofA Securities | Neutral → Buy |
| Nov-08-22 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| Oct-17-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Sep-07-22 | Initiated | Truist | Hold |
| Jul-15-22 | Initiated | SVB Leerink | Underperform |
| Apr-14-22 | Initiated | Guggenheim | Buy |
| Apr-01-22 | Resumed | Credit Suisse | Outperform |
| Mar-10-22 | Initiated | Deutsche Bank | Hold |
| Dec-02-21 | Initiated | Jefferies | Hold |
| Nov-11-21 | Upgrade | Piper Sandler | Neutral → Overweight |
| Jul-06-21 | Initiated | BofA Securities | Neutral |
| May-20-21 | Upgrade | Credit Suisse | Neutral → Outperform |
| Apr-21-21 | Initiated | Truist | Hold |
| Mar-09-21 | Initiated | Credit Suisse | Neutral |
| Mar-02-21 | Upgrade | Citigroup | Neutral → Buy |
| Feb-17-21 | Initiated | Citigroup | Neutral |
| Feb-12-21 | Initiated | Piper Sandler | Neutral |
| Feb-08-21 | Initiated | Tigress Financial | Buy |
View All
Hims Hers Health Inc Stock (HIMS) Latest News
Spotlight on Hims & Hers Health: Analyzing the Surge in Options Activity - Benzinga
Hims & Hers Health (HIMS) Reaches New High Amid FDA Nomination S - GuruFocus.com
Blueshift Asset Management LLC Acquires 218,804 Shares of Hims & Hers Health, Inc. (NYSE:HIMS) - MarketBeat
Massachusetts Financial Services Co. MA Purchases Shares of 130,017 Hims & Hers Health, Inc. (NYSE:HIMS) - MarketBeat
Hims & Hers CFO sells $3.02 million in stock - Investing.com
Hims & Hers Health's chief legal officer sells $70,055 in stock - Investing.com
Hims & Hers Shares Jump as Trump FDA Pick Seen as Major Ally - MSN
Why Hims & Hers Stock Jumped on Massive FDA News - The Motley Fool
Why Investors Shouldn't Be Surprised By Hims & Hers Health, Inc.'s (NYSE:HIMS) 44% Share Price Surge - Simply Wall St
Hims & Hers Health Inc (HIMS) Stock Price Up 14.53% on Nov 25 - GuruFocus.com
What's Going On With Hims & Hers Health Stock Monday? - Benzinga
Hims & Hers Shares Jump as Trump’s FDA Pick Seen as Major Ally - Bloomberg
Hims & Hers surges: Analysts say it's well-positioned under Trump - Yahoo Finance
Hims & Hers (HIMS) Stock Surges Amid Potential FDA Leadership Ch - GuruFocus.com
HIMS Stock Soars to All-Time High, Reaching $30.45 - Investing.com India
Hims & Hers up 18% amid optimism for compounders with Makary FDA pick - Seeking Alpha
Hims & Hers Health gain on potential FDA leadership ties - Investing.com
Hims & Hers Health gain on potential FDA leadership ties By Investing.com - Investing.com Australia
BofA reiterates underperform rating on HIMS shares amid FDA leadership change - Investing.com
DRW Securities LLC Buys Shares of 109,504 Hims & Hers Health, Inc. (NYSE:HIMS) - MarketBeat
Penserra Capital Management LLC Sells 91,424 Shares of Hims & Hers Health, Inc. (NYSE:HIMS) - MarketBeat
Him & Hers Health Stock Doubled Options Bulls' Money - Schaeffers Research
Applied Digital And Hims & Hers Health Are Among Top 9 Mid-Cap Gainers Last Week (Nov 18-Nov 22): Are The Others In Your Portfolio? - Benzinga
29,986 Shares in Hims & Hers Health, Inc. (NYSE:HIMS) Purchased by Alpha DNA Investment Management LLC - MarketBeat
HIMS (Hims & Hers Health) Cash From Other Investing Activit - GuruFocus.com
Noteworthy Friday Option Activity: HIMS, AMBA, VZ - Nasdaq
Bulls: Bet on a Rebound for This Telehealth Stock - Schaeffers Research
Hims & Hers New Growth Category Is a Huge Surprise - Nasdaq
Hims & Hers Add Bars & Shakes for GLP-1 Users - Athletech News
The FDA Can’t Decide Whether Zepbound Is in Shortage. Hims & Hers Stock Jumps. - Barron's
Weight Wellness Nutrition Supplements - Trend Hunter
Hims & Hers Health, Inc. (HIMS) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
3 US Growth Companies With High Insider Ownership Seeing Up To 40% Earnings Growth - Simply Wall St
Hims & Hers Health expands board, appoints new director - Investing.com
Hims & Hers Stock’s Retail Army Brushes Off Amazon Medical One’s Rival Service Even As Citi Sees Threat - MSN
Hims & Hers’ stock tumbles on Amazon’s latest disruptive foray into healthcare - MSN
Hims & Hers Health Expands Board with New Appointment - TipRanks
Hims & Hers closes up 10% as Lilly tirzepatide compounding dispute resolution delayed - Seeking Alpha
Amazon’s One Medical forms new telehealth service to compete with DTC players - Healthcare Brew
Hims & Hers Expands Nutrition Support to Fuel Customers’ Weight Loss Journeys - Joplin Globe
Hims & Hers Launches Premium Weight Loss Subscription with Protein-Rich Meal Replacements | HIMS Stock News - StockTitan
January 2025 Options Now Available For Hims & Hers Health (HIMS) - Nasdaq
Landscape Capital Management L.L.C. Trims Holdings in Hims & Hers Health, Inc. (NYSE:HIMS) - MarketBeat
Principal Financial Group Inc. Buys 146,621 Shares of Hims & Hers Health, Inc. (NYSE:HIMS) - MarketBeat
Hims & Hers Health, Inc. (NYSE:HIMS) Receives $20.71 Average Price Target from Brokerages - MarketBeat
Amazon's push into telehealth knocks shares of Hims & Hers - MSN
Amazon Sets Sights on Both Hims & Hers and Temu. Is This a Golden Opportunity to Buy the Stock? - AOL
Hims & Hers health officer sells stock for $9,166 - Investing.com India
Hims & Hers stock falls as Amazon launches Telehealth offering - MSN
Will Amazon Bury Hims Stock or Should You Buy the Dip? - Yahoo Finance
Hims & Hers Health: Far From Dead, Even With Amazon's Threat Ahead (NYSE:HIMS) - Seeking Alpha
Hims Hers Health Inc Stock (HIMS) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.30%
0.12%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):